Q&A

Better Therapeutic Outcomes From Better Drug Delivery

Source: Celanese
iStock-1232630835-patient-doctor

In the evolving world of medicine, long-acting dosage forms are becoming more prevalent in the drug development pipeline. These forms are ideal for providing targeted drug release with continuous drug administration, ensuring patient adherence, which is of particular importance when compliance is crucial to treatment response. In addition, these dosage forms contribute to improved safety and efficacy through better dosing. Celanese Corporation’s pharmaceutical business works closely with its customers to create innovative drug-eluting implants, inserts, and transdermal films delivering biologics and small molecules to meet the goals of patient-centric therapies, improved medicine, and better healthcare economics. Laura Brand, Vice President of Celanese’s Medical & Pharmaceutical Business recently spoke about the company's drug delivery platform and the value it brings to the industry.

VIEW THE Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online